Aphria (OTCMKTS:APHQF) earns buy rating from analysts at Scotiabank

Twitter icon

Scotiabank began coverage on shares of Aphria (OTCMKTS:APHQF) in a research note issued to investors on Wednesday, October 17th. The brokerage issued a buy rating on the stock. Separately, Cann initiated coverage on shares of Aphria in a report on Friday, October 12th. They set a sell rating and a $19.00 price target for the company.

Shares of OTCMKTS:APHQF traded down $0.30 during trading on Wednesday, hitting $12.31. The company’s stock had a trading volume of 4,299,881 shares, compared to its average volume of 2,530,405. Aphria has a fifty-two week low of $5.86 and a fifty-two week high of $19.87.

About Aphria

Aphria Inc produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc is headquartered in Leamington, Canada.

e-mail icon Facebook icon Twitter icon LinkedIn icon Reddit icon
Rate this article: 
Regional Marijuana News: